Menu
Recruiting NCT07122219

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

No phase Interventional HIV Hepatitis C Virus (HCV)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: NIATx.
Who it may be relevant to
Registry conditions: HIV, Hepatitis C Virus (HCV). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.

Detailed description

Using a step-wedge design, we will conduct a Type 2 hybrid implementation trial to assess the extent to which PNEP uptake is improved over 24 months of observation using the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy bundle. Nine prisons were non-randomly\* allocated to one of three groups, with the groups receiving the intervention (i.e., NIATx) over 24 months at staggered time intervals (every 6 months). This will be followed by an additional 12 month post-intervention period, when sustainability will be assessed.

\*Originally randomized; allocation was modified due to logistical constraints

Interventions

  • Behavioral NIATx
    The Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.

Primary outcome measures

  • Effectiveness [Time frame: From start to end of intervention period (24 months)]
Secondary outcome measures (2)
  • Bloodborne virus cascade of care [Time frame: From start to end of intervention period (24 months)]
  • Enrollment in opioid agonist therapy [Time frame: From start to end of intervention period (24 months)]

Eligibility criteria

Inclusion criteria

  • All people incarcerated at a study site during the intervention period

Exclusion criteria

\- None (site level intervention)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Sequential
Masking
Open label
Primary purpose
Health services research

Study locations

Canada · 9 centers
  • Edmonton Institution for Women — Edmonton
  • Fraser Valley Institution for Women — Abbotsford British Columbia
  • Mission Institution — Mission
  • Dorchester Medium — Dorchester
  • Atlantic Institution — Smiths Crossing
  • Nova Institution for Women — Truro
  • Joyceville Institution — Kingston
  • Grand Valley Institution for Women — Kitchener
  • … and 1 more center

Identifiers

NCT: NCT07122219 · 2023-9201 · 195710

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗